サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1393751

世界の呼吸器疾患におけるAI市場：考察と予測 (2029年まで)

Global AI in Respiratory Diseases Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の呼吸器疾患におけるAI市場：考察と予測 (2029年まで)
出版日: 2023年12月11日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、呼吸器疾患におけるAI (AI in Respiratory Diseases) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の呼吸器疾患におけるAIの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Pulmonary Infection
    • MRI
    • CT Scan
  • 市場：用途別
    • 世界の呼吸器疾患におけるAIの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospital
    • Diagnostic Centers
    • Ambulatory Surgical Centers
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の呼吸器疾患におけるAIの市場展望 (2018-2029)
  • 世界の呼吸器疾患におけるAIの市場成長トレンド：地域別
    • 呼吸器疾患におけるAI 市場規模：地域別: 2018 VS 2022 VS 2029
    • 呼吸器疾患におけるAIの市場規模実績：地域別 (2018-2023)
    • 呼吸器疾患におけるAIの市場規模予測：地域別 (2024-2029)
  • 呼吸器疾患におけるAI 市場動向
    • 呼吸器疾患におけるAI 業界動向
    • 呼吸器疾患におけるAI 市場の促進要因
    • 呼吸器疾患におけるAI 市場の課題
    • 呼吸器疾患におけるAI 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 呼吸器疾患におけるAI ：競合別
    • 世界の呼吸器疾患におけるAIの収益：企業別 (2018-2023)
    • 世界の呼吸器疾患におけるAIの収益シェア：企業別 (2018-2023)
  • 世界の呼吸器疾患におけるAIの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 呼吸器疾患におけるAI, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の呼吸器疾患におけるAI 市場集中度
    • 世界の呼吸器疾患におけるAI 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 呼吸器疾患におけるAIの収益 2022
  • 世界の主要企業 呼吸器疾患におけるAI 本社 および提供地域
  • 世界の主要企業 呼吸器疾患におけるAI, 製品およびアプリケーション
  • 世界の主要企業 呼吸器疾患におけるAI, 業界参入時期
  • M&A, 拡張計画

第4章 呼吸器疾患におけるAI 内訳データ：タイプ別

  • 世界の呼吸器疾患におけるAIの市場規模実績：タイプ別 (2018-2023)
  • 世界の呼吸器疾患におけるAIの市場規模予測：タイプ別 (2024-2029)

第5章 呼吸器疾患におけるAI 内訳データ：用途別

  • 世界の呼吸器疾患におけるAIの市場規模実績：用途別 (2018-2023)
  • 世界の呼吸器疾患におけるAIの市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の呼吸器疾患におけるAI 市場規模 (2018-2029)
  • 北米の呼吸器疾患におけるAI 市場規模：タイプ別
    • 北米の呼吸器疾患におけるAI 市場規模：タイプ別 (2018-2023)
    • 北米の呼吸器疾患におけるAI 市場規模：タイプ別 (2024-2029)
    • 北米の呼吸器疾患におけるAIの市場シェア：タイプ別 (2018-2029)
  • 北米の呼吸器疾患におけるAI 市場規模：用途別
    • 北米の呼吸器疾患におけるAI 市場規模：用途別 (2018-2023)
    • 北米の呼吸器疾患におけるAI 市場規模：用途別 (2024-2029)
    • 北米の呼吸器疾患におけるAIの市場シェア：用途別 (2018-2029)
  • 北米の呼吸器疾患におけるAI 市場規模：国別
    • 北米の呼吸器疾患におけるAI 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の呼吸器疾患におけるAI 市場規模：国別 (2018-2023)
    • 北米の呼吸器疾患におけるAI 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の呼吸器疾患におけるAI 市場規模 (2018-2029)
  • 欧州の呼吸器疾患におけるAI 市場規模：タイプ別
    • 欧州の呼吸器疾患におけるAI 市場規模：タイプ別 (2018-2023)
    • 欧州の呼吸器疾患におけるAI 市場規模：タイプ別 (2024-2029)
    • 欧州の呼吸器疾患におけるAIの市場シェア：タイプ別 (2018-2029)
  • 欧州の呼吸器疾患におけるAI 市場規模：用途別
    • 欧州の呼吸器疾患におけるAI 市場規模：用途別 (2018-2023)
    • 欧州の呼吸器疾患におけるAI 市場規模：用途別 (2024-2029)
    • 欧州の呼吸器疾患におけるAIの市場シェア：用途別 (2018-2029)
  • 欧州の呼吸器疾患におけるAI 市場規模：国別
    • 欧州の呼吸器疾患におけるAI 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の呼吸器疾患におけるAI 市場規模：国別 (2018-2023)
    • 欧州の呼吸器疾患におけるAI 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の呼吸器疾患におけるAI 市場規模 (2018-2029)
  • 中国の呼吸器疾患におけるAI 市場規模：タイプ別
    • 中国の呼吸器疾患におけるAI 市場規模：タイプ別 (2018-2023)
    • 中国の呼吸器疾患におけるAI 市場規模：タイプ別 (2024-2029)
    • 中国の呼吸器疾患におけるAIの市場シェア：タイプ別 (2018-2029)
  • 中国の呼吸器疾患におけるAI 市場規模：用途別
    • 中国の呼吸器疾患におけるAI 市場規模：用途別 (2018-2023)
    • 中国の呼吸器疾患におけるAI 市場規模：用途別 (2024-2029)
    • 中国の呼吸器疾患におけるAIの市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 呼吸器疾患におけるAI 市場規模 (2018-2029)
  • アジア地域 呼吸器疾患におけるAI 市場規模：タイプ別
    • アジア地域 呼吸器疾患におけるAI 市場規模：タイプ別 (2018-2023)
    • アジア地域 呼吸器疾患におけるAI 市場規模：タイプ別 (2024-2029)
    • アジア地域 呼吸器疾患におけるAIの市場シェア：タイプ別 (2018-2029)
  • アジア地域 呼吸器疾患におけるAI 市場規模：用途別
    • アジア地域 呼吸器疾患におけるAI 市場規模：用途別 (2018-2023)
    • アジア地域 呼吸器疾患におけるAI 市場規模：用途別 (2024-2029)
    • アジア地域 呼吸器疾患におけるAIの市場シェア：用途別 (2018-2029)
  • アジア地域 呼吸器疾患におけるAI 市場規模：地域別
    • アジア地域 呼吸器疾患におけるAI 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 呼吸器疾患におけるAI 市場規模：地域別 (2018-2023)
    • アジア地域 呼吸器疾患におけるAI 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：タイプ別
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAIの市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：用途別
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAIの市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：国別
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 呼吸器疾患におけるAI 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • ArtiQ
  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthineers
  • Swaasa AI
  • THIRONA
  • DeepMind Health
  • Verily
  • VIDA Diagnostics Inc
  • Icometrix
  • Infervision
  • PneumoWave
  • Respiray
  • Dectrocel Healthcare
  • Zynnon

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global AI in Respiratory Diseases Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Pulmonary Infection
  • Table 3. Key Players of MRI
  • Table 4. Key Players of CT Scan
  • Table 5. Global AI in Respiratory Diseases Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global AI in Respiratory Diseases Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global AI in Respiratory Diseases Market Share by Region (2018-2023)
  • Table 9. Global AI in Respiratory Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global AI in Respiratory Diseases Market Share by Region (2024-2029)
  • Table 11. AI in Respiratory Diseases Market Trends
  • Table 12. AI in Respiratory Diseases Market Drivers
  • Table 13. AI in Respiratory Diseases Market Challenges
  • Table 14. AI in Respiratory Diseases Market Restraints
  • Table 15. Global AI in Respiratory Diseases Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global AI in Respiratory Diseases Revenue Share by Players (2018-2023)
  • Table 17. Global Top AI in Respiratory Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Respiratory Diseases as of 2022)
  • Table 18. Global AI in Respiratory Diseases Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by AI in Respiratory Diseases Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of AI in Respiratory Diseases, Headquarters and Area Served
  • Table 21. Global Key Players of AI in Respiratory Diseases, Product and Application
  • Table 22. Global Key Players of AI in Respiratory Diseases, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global AI in Respiratory Diseases Revenue Market Share by Type (2018-2023)
  • Table 26. Global AI in Respiratory Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global AI in Respiratory Diseases Revenue Market Share by Type (2024-2029)
  • Table 28. Global AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global AI in Respiratory Diseases Revenue Share by Application (2018-2023)
  • Table 30. Global AI in Respiratory Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global AI in Respiratory Diseases Revenue Share by Application (2024-2029)
  • Table 32. North America AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America AI in Respiratory Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America AI in Respiratory Diseases Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America AI in Respiratory Diseases Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe AI in Respiratory Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe AI in Respiratory Diseases Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe AI in Respiratory Diseases Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia AI in Respiratory Diseases Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia AI in Respiratory Diseases Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia AI in Respiratory Diseases Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America AI in Respiratory Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. ArtiQ Company Details
  • Table 65. ArtiQ Business Overview
  • Table 66. ArtiQ AI in Respiratory Diseases Product
  • Table 67. ArtiQ Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 68. ArtiQ Recent Developments
  • Table 69. Philips Healthcare Company Details
  • Table 70. Philips Healthcare Business Overview
  • Table 71. Philips Healthcare AI in Respiratory Diseases Product
  • Table 72. Philips Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 73. Philips Healthcare Recent Developments
  • Table 74. GE Healthcare Company Details
  • Table 75. GE Healthcare Business Overview
  • Table 76. GE Healthcare AI in Respiratory Diseases Product
  • Table 77. GE Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 78. GE Healthcare Recent Developments
  • Table 79. Siemens Healthineers Company Details
  • Table 80. Siemens Healthineers Business Overview
  • Table 81. Siemens Healthineers AI in Respiratory Diseases Product
  • Table 82. Siemens Healthineers Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 83. Siemens Healthineers Recent Developments
  • Table 84. Swaasa AI Company Details
  • Table 85. Swaasa AI Business Overview
  • Table 86. Swaasa AI AI in Respiratory Diseases Product
  • Table 87. Swaasa AI Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 88. Swaasa AI Recent Developments
  • Table 89. THIRONA Company Details
  • Table 90. THIRONA Business Overview
  • Table 91. THIRONA AI in Respiratory Diseases Product
  • Table 92. THIRONA Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 93. THIRONA Recent Developments
  • Table 94. DeepMind Health Company Details
  • Table 95. DeepMind Health Business Overview
  • Table 96. DeepMind Health AI in Respiratory Diseases Product
  • Table 97. DeepMind Health Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 98. DeepMind Health Recent Developments
  • Table 99. Verily Company Details
  • Table 100. Verily Business Overview
  • Table 101. Verily AI in Respiratory Diseases Product
  • Table 102. Verily Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 103. Verily Recent Developments
  • Table 104. VIDA Diagnostics Inc Company Details
  • Table 105. VIDA Diagnostics Inc Business Overview
  • Table 106. VIDA Diagnostics Inc AI in Respiratory Diseases Product
  • Table 107. VIDA Diagnostics Inc Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 108. VIDA Diagnostics Inc Recent Developments
  • Table 109. Icometrix Company Details
  • Table 110. Icometrix Business Overview
  • Table 111. Icometrix AI in Respiratory Diseases Product
  • Table 112. Icometrix Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 113. Icometrix Recent Developments
  • Table 114. Infervision Company Details
  • Table 115. Infervision Business Overview
  • Table 116. Infervision AI in Respiratory Diseases Product
  • Table 117. Infervision Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 118. Infervision Recent Developments
  • Table 119. PneumoWave Company Details
  • Table 120. PneumoWave Business Overview
  • Table 121. PneumoWave AI in Respiratory Diseases Product
  • Table 122. PneumoWave Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 123. PneumoWave Recent Developments
  • Table 124. Respiray Company Details
  • Table 125. Respiray Business Overview
  • Table 126. Respiray AI in Respiratory Diseases Product
  • Table 127. Respiray Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 128. Respiray Recent Developments
  • Table 129. Dectrocel Healthcare Company Details
  • Table 130. Dectrocel Healthcare Business Overview
  • Table 131. Dectrocel Healthcare AI in Respiratory Diseases Product
  • Table 132. Dectrocel Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 133. Dectrocel Healthcare Recent Developments
  • Table 134. Zynnon Company Details
  • Table 135. Zynnon Business Overview
  • Table 136. Zynnon AI in Respiratory Diseases Product
  • Table 137. Zynnon Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
  • Table 138. Zynnon Recent Developments
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global AI in Respiratory Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global AI in Respiratory Diseases Market Share by Type: 2022 VS 2029
  • Figure 3. Pulmonary Infection Features
  • Figure 4. MRI Features
  • Figure 5. CT Scan Features
  • Figure 6. Global AI in Respiratory Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global AI in Respiratory Diseases Market Share by Application: 2022 VS 2029
  • Figure 8. Hospital Case Studies
  • Figure 9. Diagnostic Centers Case Studies
  • Figure 10. Ambulatory Surgical Centers Case Studies
  • Figure 11. Others Case Studies
  • Figure 12. AI in Respiratory Diseases Report Years Considered
  • Figure 13. Global AI in Respiratory Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 14. Global AI in Respiratory Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global AI in Respiratory Diseases Market Share by Region: 2022 VS 2029
  • Figure 16. Global AI in Respiratory Diseases Market Share by Players in 2022
  • Figure 17. Global Top AI in Respiratory Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Respiratory Diseases as of 2022)
  • Figure 18. The Top 10 and 5 Players Market Share by AI in Respiratory Diseases Revenue in 2022
  • Figure 19. North America AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 20. North America AI in Respiratory Diseases Market Share by Type (2018-2029)
  • Figure 21. North America AI in Respiratory Diseases Market Share by Application (2018-2029)
  • Figure 22. North America AI in Respiratory Diseases Market Share by Country (2018-2029)
  • Figure 23. United States AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Canada AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Europe AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
  • Figure 26. Europe AI in Respiratory Diseases Market Share by Type (2018-2029)
  • Figure 27. Europe AI in Respiratory Diseases Market Share by Application (2018-2029)
  • Figure 28. Europe AI in Respiratory Diseases Market Share by Country (2018-2029)
  • Figure 29. Germany AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. France AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. U.K. AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Italy AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Russia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Nordic Countries AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. China AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
  • Figure 36. China AI in Respiratory Diseases Market Share by Type (2018-2029)
  • Figure 37. China AI in Respiratory Diseases Market Share by Application (2018-2029)
  • Figure 38. Asia AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
  • Figure 39. Asia AI in Respiratory Diseases Market Share by Type (2018-2029)
  • Figure 40. Asia AI in Respiratory Diseases Market Share by Application (2018-2029)
  • Figure 41. Asia AI in Respiratory Diseases Market Share by Region (2018-2029)
  • Figure 42. Japan AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. South Korea AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. China Taiwan AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Southeast Asia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. India AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Australia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Type (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Application (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Country (2018-2029)
  • Figure 52. Brazil AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Mexico AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Turkey AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Saudi Arabia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Israel AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. GCC Countries AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. ArtiQ Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 59. Philips Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 60. GE Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 61. Siemens Healthineers Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 62. Swaasa AI Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 63. THIRONA Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 64. DeepMind Health Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 65. Verily Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 66. VIDA Diagnostics Inc Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 67. Icometrix Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 68. Infervision Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 69. PneumoWave Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 70. Respiray Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 71. Dectrocel Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 72. Zynnon Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
  • Figure 73. Bottom-up and Top-down Approaches for This Report
  • Figure 74. Data Triangulation
  • Figure 75. Key Executives Interviewed
目次

This research report focuses on the AI in Respiratory Diseases Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global AI in Respiratory Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Pulmonary Infection
    • 1.2.3 MRI
    • 1.2.4 CT Scan
  • 1.3 Market by Application
    • 1.3.1 Global AI in Respiratory Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Diagnostic Centers
    • 1.3.4 Ambulatory Surgical Centers
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global AI in Respiratory Diseases Market Perspective (2018-2029)
  • 2.2 Global AI in Respiratory Diseases Growth Trends by Region
    • 2.2.1 AI in Respiratory Diseases Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 AI in Respiratory Diseases Historic Market Size by Region (2018-2023)
    • 2.2.3 AI in Respiratory Diseases Forecasted Market Size by Region (2024-2029)
  • 2.3 AI in Respiratory Diseases Market Dynamics
    • 2.3.1 AI in Respiratory Diseases Industry Trends
    • 2.3.2 AI in Respiratory Diseases Market Drivers
    • 2.3.3 AI in Respiratory Diseases Market Challenges
    • 2.3.4 AI in Respiratory Diseases Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue AI in Respiratory Diseases by Players
    • 3.1.1 Global AI in Respiratory Diseases Revenue by Players (2018-2023)
    • 3.1.2 Global AI in Respiratory Diseases Revenue Market Share by Players (2018-2023)
  • 3.2 Global AI in Respiratory Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of AI in Respiratory Diseases, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global AI in Respiratory Diseases Market Concentration Ratio
    • 3.4.1 Global AI in Respiratory Diseases Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by AI in Respiratory Diseases Revenue in 2022
  • 3.5 Global Key Players of AI in Respiratory Diseases Head office and Area Served
  • 3.6 Global Key Players of AI in Respiratory Diseases, Product and Application
  • 3.7 Global Key Players of AI in Respiratory Diseases, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 AI in Respiratory Diseases Breakdown Data by Type

  • 4.1 Global AI in Respiratory Diseases Historic Market Size by Type (2018-2023)
  • 4.2 Global AI in Respiratory Diseases Forecasted Market Size by Type (2024-2029)

5 AI in Respiratory Diseases Breakdown Data by Application

  • 5.1 Global AI in Respiratory Diseases Historic Market Size by Application (2018-2023)
  • 5.2 Global AI in Respiratory Diseases Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America AI in Respiratory Diseases Market Size (2018-2029)
  • 6.2 North America AI in Respiratory Diseases Market Size by Type
    • 6.2.1 North America AI in Respiratory Diseases Market Size by Type (2018-2023)
    • 6.2.2 North America AI in Respiratory Diseases Market Size by Type (2024-2029)
    • 6.2.3 North America AI in Respiratory Diseases Market Share by Type (2018-2029)
  • 6.3 North America AI in Respiratory Diseases Market Size by Application
    • 6.3.1 North America AI in Respiratory Diseases Market Size by Application (2018-2023)
    • 6.3.2 North America AI in Respiratory Diseases Market Size by Application (2024-2029)
    • 6.3.3 North America AI in Respiratory Diseases Market Share by Application (2018-2029)
  • 6.4 North America AI in Respiratory Diseases Market Size by Country
    • 6.4.1 North America AI in Respiratory Diseases Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America AI in Respiratory Diseases Market Size by Country (2018-2023)
    • 6.4.3 North America AI in Respiratory Diseases Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe AI in Respiratory Diseases Market Size (2018-2029)
  • 7.2 Europe AI in Respiratory Diseases Market Size by Type
    • 7.2.1 Europe AI in Respiratory Diseases Market Size by Type (2018-2023)
    • 7.2.2 Europe AI in Respiratory Diseases Market Size by Type (2024-2029)
    • 7.2.3 Europe AI in Respiratory Diseases Market Share by Type (2018-2029)
  • 7.3 Europe AI in Respiratory Diseases Market Size by Application
    • 7.3.1 Europe AI in Respiratory Diseases Market Size by Application (2018-2023)
    • 7.3.2 Europe AI in Respiratory Diseases Market Size by Application (2024-2029)
    • 7.3.3 Europe AI in Respiratory Diseases Market Share by Application (2018-2029)
  • 7.4 Europe AI in Respiratory Diseases Market Size by Country
    • 7.4.1 Europe AI in Respiratory Diseases Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe AI in Respiratory Diseases Market Size by Country (2018-2023)
    • 7.4.3 Europe AI in Respiratory Diseases Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China AI in Respiratory Diseases Market Size (2018-2029)
  • 8.2 China AI in Respiratory Diseases Market Size by Type
    • 8.2.1 China AI in Respiratory Diseases Market Size by Type (2018-2023)
    • 8.2.2 China AI in Respiratory Diseases Market Size by Type (2024-2029)
    • 8.2.3 China AI in Respiratory Diseases Market Share by Type (2018-2029)
  • 8.3 China AI in Respiratory Diseases Market Size by Application
    • 8.3.1 China AI in Respiratory Diseases Market Size by Application (2018-2023)
    • 8.3.2 China AI in Respiratory Diseases Market Size by Application (2024-2029)
    • 8.3.3 China AI in Respiratory Diseases Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia AI in Respiratory Diseases Market Size (2018-2029)
  • 9.2 Asia AI in Respiratory Diseases Market Size by Type
    • 9.2.1 Asia AI in Respiratory Diseases Market Size by Type (2018-2023)
    • 9.2.2 Asia AI in Respiratory Diseases Market Size by Type (2024-2029)
    • 9.2.3 Asia AI in Respiratory Diseases Market Share by Type (2018-2029)
  • 9.3 Asia AI in Respiratory Diseases Market Size by Application
    • 9.3.1 Asia AI in Respiratory Diseases Market Size by Application (2018-2023)
    • 9.3.2 Asia AI in Respiratory Diseases Market Size by Application (2024-2029)
    • 9.3.3 Asia AI in Respiratory Diseases Market Share by Application (2018-2029)
  • 9.4 Asia AI in Respiratory Diseases Market Size by Region
    • 9.4.1 Asia AI in Respiratory Diseases Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia AI in Respiratory Diseases Market Size by Region (2018-2023)
    • 9.4.3 Asia AI in Respiratory Diseases Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 ArtiQ
    • 11.1.1 ArtiQ Company Details
    • 11.1.2 ArtiQ Business Overview
    • 11.1.3 ArtiQ AI in Respiratory Diseases Introduction
    • 11.1.4 ArtiQ Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.1.5 ArtiQ Recent Developments
  • 11.2 Philips Healthcare
    • 11.2.1 Philips Healthcare Company Details
    • 11.2.2 Philips Healthcare Business Overview
    • 11.2.3 Philips Healthcare AI in Respiratory Diseases Introduction
    • 11.2.4 Philips Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.2.5 Philips Healthcare Recent Developments
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Company Details
    • 11.3.2 GE Healthcare Business Overview
    • 11.3.3 GE Healthcare AI in Respiratory Diseases Introduction
    • 11.3.4 GE Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.3.5 GE Healthcare Recent Developments
  • 11.4 Siemens Healthineers
    • 11.4.1 Siemens Healthineers Company Details
    • 11.4.2 Siemens Healthineers Business Overview
    • 11.4.3 Siemens Healthineers AI in Respiratory Diseases Introduction
    • 11.4.4 Siemens Healthineers Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.4.5 Siemens Healthineers Recent Developments
  • 11.5 Swaasa AI
    • 11.5.1 Swaasa AI Company Details
    • 11.5.2 Swaasa AI Business Overview
    • 11.5.3 Swaasa AI AI in Respiratory Diseases Introduction
    • 11.5.4 Swaasa AI Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.5.5 Swaasa AI Recent Developments
  • 11.6 THIRONA
    • 11.6.1 THIRONA Company Details
    • 11.6.2 THIRONA Business Overview
    • 11.6.3 THIRONA AI in Respiratory Diseases Introduction
    • 11.6.4 THIRONA Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.6.5 THIRONA Recent Developments
  • 11.7 DeepMind Health
    • 11.7.1 DeepMind Health Company Details
    • 11.7.2 DeepMind Health Business Overview
    • 11.7.3 DeepMind Health AI in Respiratory Diseases Introduction
    • 11.7.4 DeepMind Health Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.7.5 DeepMind Health Recent Developments
  • 11.8 Verily
    • 11.8.1 Verily Company Details
    • 11.8.2 Verily Business Overview
    • 11.8.3 Verily AI in Respiratory Diseases Introduction
    • 11.8.4 Verily Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.8.5 Verily Recent Developments
  • 11.9 VIDA Diagnostics Inc
    • 11.9.1 VIDA Diagnostics Inc Company Details
    • 11.9.2 VIDA Diagnostics Inc Business Overview
    • 11.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Introduction
    • 11.9.4 VIDA Diagnostics Inc Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.9.5 VIDA Diagnostics Inc Recent Developments
  • 11.10 Icometrix
    • 11.10.1 Icometrix Company Details
    • 11.10.2 Icometrix Business Overview
    • 11.10.3 Icometrix AI in Respiratory Diseases Introduction
    • 11.10.4 Icometrix Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.10.5 Icometrix Recent Developments
  • 11.11 Infervision
    • 11.11.1 Infervision Company Details
    • 11.11.2 Infervision Business Overview
    • 11.11.3 Infervision AI in Respiratory Diseases Introduction
    • 11.11.4 Infervision Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.11.5 Infervision Recent Developments
  • 11.12 PneumoWave
    • 11.12.1 PneumoWave Company Details
    • 11.12.2 PneumoWave Business Overview
    • 11.12.3 PneumoWave AI in Respiratory Diseases Introduction
    • 11.12.4 PneumoWave Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.12.5 PneumoWave Recent Developments
  • 11.13 Respiray
    • 11.13.1 Respiray Company Details
    • 11.13.2 Respiray Business Overview
    • 11.13.3 Respiray AI in Respiratory Diseases Introduction
    • 11.13.4 Respiray Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.13.5 Respiray Recent Developments
  • 11.14 Dectrocel Healthcare
    • 11.14.1 Dectrocel Healthcare Company Details
    • 11.14.2 Dectrocel Healthcare Business Overview
    • 11.14.3 Dectrocel Healthcare AI in Respiratory Diseases Introduction
    • 11.14.4 Dectrocel Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.14.5 Dectrocel Healthcare Recent Developments
  • 11.15 Zynnon
    • 11.15.1 Zynnon Company Details
    • 11.15.2 Zynnon Business Overview
    • 11.15.3 Zynnon AI in Respiratory Diseases Introduction
    • 11.15.4 Zynnon Revenue in AI in Respiratory Diseases Business (2018-2023)
    • 11.15.5 Zynnon Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details